M&A Activity • Jul 4, 2011
M&A Activity
Open in ViewerOpens in native device viewer
PRESS RELEASE Stockholm, 4 july 2011
Bure Equity's portfolio company CMA Microdialysis sells its preclinical business and its subsidiary Dilab. CMA Microdialysis continuing operations will be renamed to Dipolyn Medical AB.
For more information see enclosed press releases and Dipylon Medicals web page:
www.dipylonmedical.com
Patrik Tigerschiöld, CEO Tel. +46 8 614 00 20
Bure Equity AB (publ)
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.